Journal Article Summary
The article examines the effectiveness of extending the use of progestin contraceptive implants beyond their currently approved durations. This topic is significant because progestin-only implants are a popular contraceptive method, known for their high efficacy and long duration of action. By exploring the potential for extended use, the study aims to enhance accessibility and convenience for women who rely on these implants for birth control.
The researchers conducted a systematic review of studies published between 1996 and 2017, focusing on randomized clinical trials, cohort studies, and case-control studies that assessed the contraceptive efficacy of implants beyond their approved usage periods. They identified six studies involving a total of 1,075 women, with findings indicating that while there were very few reported pregnancies during extended use, the overall quality of the studies was rated as poor to fair. Notably, five pregnancies occurred among women using the levonorgestrel implant, suggesting that while extended use may be effective, the evidence is limited and not robust enough to make definitive recommendations.
The review highlights several limitations, including the lack of comparative studies between women who extended their implant use and those who replaced it with a new implant. The small sample sizes and potential biases in the studies raise concerns about the generalizability of the findings. Patients considering extending the duration of their contraceptive implants should discuss their individual circumstances with a healthcare professional, taking into account their medical history and the implications of an unintended pregnancy. It is essential for women to weigh the risks and benefits of extending implant use in a shared decision-making process with their providers.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Thaxton Lauren, Lavelanet Antonella. Systematic review of efficacy with extending contraceptive implant duration. International Journal of Gynaecology and Obstetrics 2018. DOI: 10.1002/ijgo.12696. PMID: 30343503. PMCID: PMC7379677.
Featured Pill Pals Product
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) --- Perrigo --- Over The Counter
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) — Perrigo — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
